Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
第一作者:
S M,Swain
第一单位:
Comprehensive Breast Center, Washington, DC 20015-2034, USA. swainsm@aol.com
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);心血管药物(Cardiovascular Agents);环磷酰胺(Cyclophosphamide);无病生存(Disease-Free Survival);双盲法(Double-Blind Method);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);女(雌)性(Female);氟尿嘧啶(Fluorouracil);心力衰竭(Heart Failure);人类(Humans);中年人(Middle Aged);前瞻性研究(Prospective Studies);丙亚胺(Razoxane);治疗结果(Treatment Outcome)
DOI
10.1200/JCO.1997.15.4.1333
PMID
9193324
发布时间
2017-02-10
- 浏览55

Journal of clinical oncology
1333-40页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文